CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain

200936 citationsJournal Article

Authors

Good health and well-being

Published in: European Journal of Pharmacology

Volume 617, Issue 1-3, pp. 59-67

Field-Weighted Citation Impact: 2.87